Annual EBITDA
-$36.71 M
-$23.29 M-173.66%
December 31, 2023
Summary
- As of February 7, 2025, ONCO annual EBITDA is -$36.71 million, with the most recent change of -$23.29 million (-173.66%) on December 31, 2023.
- During the last 3 years, ONCO annual EBITDA has fallen by -$35.09 million (-2167.25%).
- ONCO annual EBITDA is now -4072.64% below its all-time high of -$879.70 thousand, reached on December 1, 2019.
Performance
ONCO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.29 M
+$10.40 M+75.94%
September 30, 2024
Summary
- As of February 7, 2025, ONCO quarterly EBITDA is -$3.29 million, with the most recent change of +$10.40 million (+75.94%) on September 30, 2024.
- Over the past year, ONCO quarterly EBITDA has increased by +$7.33 million (+68.98%).
- ONCO quarterly EBITDA is now -915.35% below its all-time high of -$324.50 thousand, reached on March 1, 2021.
Performance
ONCO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$49.74 M
+$1.78 M+3.46%
September 30, 2024
Summary
- As of February 7, 2025, ONCO TTM EBITDA is -$49.74 million, with the most recent change of +$1.78 million (+3.46%) on September 30, 2024.
- Over the past year, ONCO TTM EBITDA has dropped by -$5.26 million (-11.83%).
- ONCO TTM EBITDA is now -12200.79% below its all-time high of -$404.40 thousand, reached on December 1, 2020.
Performance
ONCO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ONCO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -173.7% | +69.0% | -11.8% |
| 3 y3 years | -2167.3% | +69.0% | -11.8% |
| 5 y5 years | -4072.6% | +69.0% | -11.8% |
ONCO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -975.7% | at low | -174.1% | +85.1% | -1357.8% | +3.5% |
| 5 y | 5-year | -4072.6% | at low | -915.4% | +85.1% | <-9999.0% | +3.5% |
| alltime | all time | -4072.6% | at low | -915.4% | +85.1% | <-9999.0% | +3.5% |
Onconetix EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.29 M(-75.9%) | -$49.74 M(-3.5%) |
| Jun 2024 | - | -$13.69 M(+28.9%) | -$51.53 M(+15.8%) |
| Mar 2024 | - | -$10.62 M(-52.0%) | -$44.48 M(+21.2%) |
| Dec 2023 | -$36.71 M(+173.7%) | -$22.14 M(+336.1%) | -$36.71 M(+106.4%) |
| Sep 2023 | - | -$5.08 M(-23.7%) | -$17.79 M(+7.3%) |
| Jun 2023 | - | -$6.65 M(+133.7%) | -$16.58 M(+16.8%) |
| Mar 2023 | - | -$2.84 M(-11.5%) | -$14.19 M(+5.8%) |
| Dec 2022 | -$13.41 M | - | - |
| Dec 2022 | - | -$3.22 M(-16.8%) | -$13.41 M(+17.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$3.86 M(-9.3%) | -$11.40 M(+32.1%) |
| Jun 2022 | - | -$4.26 M(+106.0%) | -$8.63 M(+67.3%) |
| Mar 2022 | - | -$2.07 M(+72.1%) | -$5.16 M(+51.1%) |
| Dec 2021 | -$3.41 M(+110.8%) | -$1.20 M(+9.8%) | -$3.41 M(+30.5%) |
| Sep 2021 | - | -$1.09 M(+38.4%) | -$2.61 M(+72.0%) |
| Jun 2021 | - | -$791.00 K(+143.8%) | -$1.52 M(+108.5%) |
| Mar 2021 | - | -$324.50 K(-19.8%) | -$728.90 K(+80.2%) |
| Dec 2020 | -$1.62 M(+84.0%) | -$404.40 K | -$404.40 K |
| Dec 2019 | -$879.70 K | - | - |
FAQ
- What is Onconetix annual EBITDA?
- What is the all time high annual EBITDA for Onconetix?
- What is Onconetix annual EBITDA year-on-year change?
- What is Onconetix quarterly EBITDA?
- What is the all time high quarterly EBITDA for Onconetix?
- What is Onconetix quarterly EBITDA year-on-year change?
- What is Onconetix TTM EBITDA?
- What is the all time high TTM EBITDA for Onconetix?
- What is Onconetix TTM EBITDA year-on-year change?
What is Onconetix annual EBITDA?
The current annual EBITDA of ONCO is -$36.71 M
What is the all time high annual EBITDA for Onconetix?
Onconetix all-time high annual EBITDA is -$879.70 K
What is Onconetix annual EBITDA year-on-year change?
Over the past year, ONCO annual EBITDA has changed by -$23.29 M (-173.66%)
What is Onconetix quarterly EBITDA?
The current quarterly EBITDA of ONCO is -$3.29 M
What is the all time high quarterly EBITDA for Onconetix?
Onconetix all-time high quarterly EBITDA is -$324.50 K
What is Onconetix quarterly EBITDA year-on-year change?
Over the past year, ONCO quarterly EBITDA has changed by +$7.33 M (+68.98%)
What is Onconetix TTM EBITDA?
The current TTM EBITDA of ONCO is -$49.74 M
What is the all time high TTM EBITDA for Onconetix?
Onconetix all-time high TTM EBITDA is -$404.40 K
What is Onconetix TTM EBITDA year-on-year change?
Over the past year, ONCO TTM EBITDA has changed by -$5.26 M (-11.83%)